• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS, INC. PHILIPS RESPIRONICS CPAP TRILOGY; CONTINUOUS, VENTILATOR, HOME USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS, INC. PHILIPS RESPIRONICS CPAP TRILOGY; CONTINUOUS, VENTILATOR, HOME USE Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Cancer (3262)
Event Date 03/01/2020
Event Type  Injury  
Event Description
Stage 3 lung cancer diagnosed around (b)(6) 2020.She got a philips respironics cpap trilogy in (b)(6) 2019 and developed cancer in (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS RESPIRONICS CPAP TRILOGY
Type of Device
CONTINUOUS, VENTILATOR, HOME USE
Manufacturer (Section D)
PHILIPS / RESPIRONICS, INC.
MDR Report Key13289615
MDR Text Key284147523
Report NumberMW5106743
Device Sequence Number1
Product Code NOU
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 01/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date04/01/2024
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
DUPIXENT ; METFORMIN ; PREDNISONE; ROSUVASTATIN
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention; Other; Disability;
Patient Age66 YR
Patient SexFemale
Patient Weight120 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-